Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Rubens L. Monte-Neto"'
Publikováno v:
Microorganisms, Vol 11, Iss 4, p 1043 (2023)
Despite decades of research devoted to finding a vaccine against leishmaniasis, we are still lacking a safe and effective vaccine for humans. Given this scenario, the search for a new prophylaxis alternative for controlling leishmaniasis should be a
Externí odkaz:
https://doaj.org/article/1afa3f879b104a9b9742bbf9541767bb
Autor:
Cynthia Demicheli, Frédéric Frézard, Maria N. Melo, Priscila G. Reis, Nivaldo L. Speziali, Nelson G. Fernandes, Rubens L. Monte-Neto, Edgar H. Lizarazo-Jaimes
Publikováno v:
Molecules, Vol 17, Iss 11, Pp 12622-12635 (2012)
Two novel trivalent antimony(III) and bismuth(III) complexes with the nitrogen-donor heterocyclic ligand dipyrido[3,2-a:2',3'-c]phenazine (dppz) were synthesized and characterized as [Sb(dppz)Cl3]∙H2O∙CH3OH and [Bi(dppz)Cl3]. The crystal structur
Externí odkaz:
https://doaj.org/article/03dd2065c539440e887df3ba76e60025
Autor:
Narlize Silva Lira, Rubens L. Monte-Neto, João Guilherme B. Marchi, Antônio Cláudio da Silva Lins, Josean Fechine Tavares, Marcelo Sobral da Silva, Celidarque da Silva Dias, José Maria Barbosa-Filho, Creusioni Figueredo dos Santos, Emídio Vasconcelos Leitão da Cunha, Ulisses dos Santos Pinheiro, Raimundo Braz-Filho
Publikováno v:
Química Nova, Vol 35, Iss 11, Pp 2189-2193 (2012)
The new dibromotyrosine derivative 3,5-dibromo-4-[3'dimethylamonium]propoxyphenyl]-N,N,N-trimethylethanamonium, here referred to as aplysfistularine (1), was isolated from the marine sponge Aplysina fistularis along with 2-(3,5-dibromo-4methoxyphenyl
Externí odkaz:
https://doaj.org/article/45a6b4ae1eb743d4a996ec967e46d780
Autor:
Vinicius Maracaja-Coutinho, Frank Kramer, Alessandra Mara de Sousa, Rubens L. Monte-Neto, Alberto J. M. Martin, Zaynab Hammoud, J. Eduardo Martinez-Hernandez
Publikováno v:
Microbiology Spectrum
Microbiology Spectrum, Vol 9, Iss 2 (2021)
Microbiology Spectrum, Vol 9, Iss 2 (2021)
Leishmania parasites are the causal agent of leishmaniasis, an endemic disease in more than 90 countries worldwide. Over the years, traditional approaches focused on the parasite when developing treatments against leishmaniasis. Despite numerous atte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3e8a8c709972ddad07737d3bc71d36
http://europepmc.org/articles/PMC8528132
http://europepmc.org/articles/PMC8528132
Autor:
Rubens L. Monte-Neto, Victoria Wagner, Christopher Fernandez-Prada, Chloé Rosa-Teijeiro, Ilda d'Annessa, Audrey Corbeil, Philippe Leprohon
Publikováno v:
Parasites & Vectors
Parasites & Vectors, Vol 14, Iss 1, Pp 1-15 (2021)
Parasites & Vectors, Vol 14, Iss 1, Pp 1-15 (2021)
Background The evolution of drug resistance is one of the biggest challenges in leishmaniasis and has prompted the need for new antileishmanial drugs. Repurposing of approved drugs is a faster and very attractive strategy that is gaining supporters w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51397752874c42db0d1c3c38430cc21
http://europepmc.org/articles/PMC8399852
http://europepmc.org/articles/PMC8399852
Autor:
Flavio D. Capanema, Amanda B. Goncalves, Henrique Cordeiro Martins, Gerald Weber, Pedro Augusto Alves, Santuza M. R. Teixeira, Matheus Filgueira Bezerra, Iara A. Borges, Ellen G. de Oliveira, Flávia de S. Rocha, Gabriel Luz Wallau, Pamella Miranda, Raissa Prado Rocha, Ana Paula M. Franco-Luiz, Rubens L. Monte-Neto, Leticia T. Almeida
The COVID-19 pandemics unfolded due to the widespread SARS-CoV-2 transmission reinforced the urgent need for affordable molecular diagnostic alternative methods for massive testing screening. We present the clinical validation of a pH-dependent color
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c4a9c2da3463b7bd77215ee64f2df2b
https://doi.org/10.1101/2021.05.26.21257488
https://doi.org/10.1101/2021.05.26.21257488
Autor:
Victor Aliaga-Tobar, J. Eduardo Martinez-Hernandez, Carolina González, Vinicius Maracaja-Coutinho, Alberto J. M. Martin, Rubens L. Monte-Neto
Leishmania spp. is the causal agent of several diseases called leishmaniases, neglected diseases that seek to be eradicated in the coming years. We aimed to study the genomic structure and function of non-coding RNAs (ncRNAs) from Leishmania spp. and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f7a6cb61083d3b93bcce7d8608f6a7d
https://doi.org/10.1101/2021.05.17.444077
https://doi.org/10.1101/2021.05.17.444077
Autor:
Juliano A. Souza Silva, Luiza Guimarães Tunes, David B. Ascher, Roney S. Coimbra, Douglas E. V. Pires, Rubens L. Monte-Neto
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 111049-(2021)
Despite all efforts to provide new chemical entities to tackle leishmaniases, we are still dependent on a the limited drug arsenal, together with drawbacks like toxicity and drug-resistant parasites. Collaborative drug discovery emerged as an option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103f49fcf6d57e10750c3b3680457a31
http://www.sciencedirect.com/science/article/pii/S0753332220312415
http://www.sciencedirect.com/science/article/pii/S0753332220312415
Publikováno v:
Genes, Vol 11, Iss 722, p 722 (2020)
Genes
Genes
Leishmaniasis (Leishmania species), sleeping sickness (Trypanosoma brucei), and Chagas disease (Trypanosoma cruzi) are devastating and globally spread diseases caused by trypanosomatid parasites. At present, drugs for treating trypanosomatid diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26aa5cd259b25ecd2786cdda66f302ff
https://www.mdpi.com/2073-4425/11/7/722
https://www.mdpi.com/2073-4425/11/7/722
Autor:
Vinicius Schmitz, Mauro V. de Almeida, Heveline Silva, Roberta E. Morato, Luiza Guimarães Tunes, Frédéric Frézard, Adriana Garcia, André Luís Branco de Barros, José Dias Corrêa-Junior, Rubens L. Monte-Neto, Mário Steindel, Hélio F. Dos Santos, Nilmar Silvio Moretti
Publikováno v:
ACS infectious diseases. 6(5)
The drugs currently used to treat leishmaniases have limitations concerning cost, efficacy, and safety, making the search for new therapeutic approaches urgent. We found that the gold(I)-derived complexes were active against L. infantum and L. brazil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c02d5d7a0567e11047aa835de249735
https://pubmed.ncbi.nlm.nih.gov/32283915
https://pubmed.ncbi.nlm.nih.gov/32283915